Larvol Delta - PROCESSA-PHARMACEUTICALS-ENTERS-INTO-A-LICENSING-AGREEMENT-WITH-OCUPHIRE-PHARMA-INC-FOR-THE-DEVELOPMENT-OF-RX3117

fluorocyclopentenylcytosine (RX-3117) - Ocuphire Pharma, BioSense Global

https://www.globenewswire.com/news-release/2021/06/17/2249061/0/en/PROCESSA-PHARMACEUTICALS-ENTERS-INTO-A-LICENSING-AGREEMENT-WITH-OCUPHIRE-PHARMA-INC-FOR-THE-DEVELOPMENT-OF-RX-3117.html

Jun 17, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next